Bone cancer treatment cost in Turkey typically includes diagnostic imaging like a PET/CT scan, which costs $700 to $700, and surgical interventions such as bone resection, which runs $8,000 to $17,400. Total expenses depend on the tumor stage, prosthetic requirements, and medication cycles. Many patients see 40% to 60% savings compared to the US. Istanbul and Ankara are the primary treatment hubs.
Typical Bone Cancer Treatment Costs in Turkey
Bookimed Expert Insight: Patients with complex sarcomas benefit most from multidisciplinary centers like Anadolu Medical Center. Its affiliation with Johns Hopkins Hospital ensures access to American-standard protocols for bone tumors. For cases requiring limb-salvage surgery, specialist Onder Ofluoglu at Medical Park offers over 30 years of expertise. Medipol Mega provides advanced technology like CyberKnife for non-invasive treatment of specific metastasis cases.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Bone resection | from $8,000 | from $25,000 | from $20,000 |
| Bone deformity correction surgery | from $2,500 | from $30,000 | from $15,000 |
| Actinium-225 Therapy | from $22,955 | from $55,000 | from $45,000 |
Dr. Bülent Karagöz specializes in bone cancer with 33 years of experience of oncology experience, focusing on tumor biology and targeted therapies.
Assoc. Prof. Eda Tanrikulu brings 21 years of experience of specialized experience in medical oncology to bone cancer cases at Anadolu Medical Center.
Dr. Mustafa Solak specializes in bone cancer treatment with a fellowship from Hacettepe University Cancer Institute.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Turkey is a safe and reliable destination for bone cancer treatment. Leading hospitals maintain Joint Commission International (JCI) accreditation and employ board-certified orthopedic oncologists. Centers like Anadolu Medical Center collaborate with Johns Hopkins Medicine to provide limb-sparing surgeries and precise diagnostic protocols.
Bookimed Expert Insight: Patient volume data suggests Turkey is a primary global hub for oncology, serving over 37,000 requests. While many seek basic resection, top-tier centers like Anadolu Medical Center offer rare Actinium-225 protocols. These targeted therapies are often provided at ESMO-accredited facilities, ensuring international clinical standards are met.
Patient Consensus: Patients value the presence of dedicated translators and note the cleanliness of recovery rooms. Many highlight that the coordination of airport transfers and hospital logistics makes the complex treatment process much easier.
Turkey offers multidisciplinary bone cancer treatments including limb-sparing surgery, advanced radiotherapy, and chemotherapy. Specialized centers in Istanbul utilize JCI-accredited protocols to preserve mobility. Key options include bone resection, reconstruction with modern prostheses, and innovative nuclear medicine like Actinium-225 therapy for specific bone-related malignancies.
Bookimed Expert Insight: Anadolu Medical Center stands out because its surgeons follow Johns Hopkins Medicine standards. While most clinics focus on surgery, this center integrates nuclear medicine like Actinium-225. This offers a specialized route for patients whose bone involvement is linked to other primary cancers.
Patient Consensus: Patients emphasize finding orthopedic oncologists rather than general surgeons to ensure the best biopsy results. Many note that limb-sparing techniques are the preferred standard across top Turkish hospitals.
Bone cancer treatment in Turkey achieves 5-year survival rates between 56% and 75% depending on tumor type. Specialized JCI-accredited centers in Istanbul utilize digital PET/CT and multidisciplinary tumor boards. These institutions report success rates reaching 85% for surgical interventions and 80% for radiation therapy.
Bookimed Expert Insight: Anadolu Medical Center stands out because its OECI accreditation and Johns Hopkins partnership provide access to international precision-medicine guides. While many clinics offer bone resection, the presence of ESMO-certified professors like Dr. Yesim Yildirim ensures treatment plans meet European gold standards. Patients should prioritize clinics with multidisciplinary tumor boards to verify that complex margin-clearing surgeries are technically feasible.
Patient Consensus: Patients note it's important to evaluate success by whether clear margins were achieved and limbs were saved. They emphasize verifying that the surgical team includes specialized orthopedic oncologists rather than general surgeons.
Initial bone cancer treatment in Turkey typically requires 3 to 4 weeks. This period allows for diagnosis, surgery, and early recovery. Major bone resections with implant replacement or multi-stage treatments combining chemotherapy may extend your stay to several months for monitoring.
Bookimed Expert Insight: Patients often overlook the coordination gap between diagnostics and surgery. At JCI-accredited centers like Anadolu Medical Center, the affiliation with Johns Hopkins ensures protocols that condense biopsy-to-surgery timelines. This efficiency can save up to 7 days of accommodation costs for international families.
Patient Consensus: Patients note that staying near the clinic in Istanbul is vital because follow-up wound checks happen frequently during the first month. Many emphasize that having a coordinator handle hospital transfers significantly reduces the stress of traveling with limited mobility.
You can obtain a pre-travel second opinion from Turkish bone cancer specialists by submitting medical records for remote review. Leading oncologists at JCI-accredited institutions like Anadolu Medical Center and Memorial Health Group provide these evaluations. Doctors use MRI scans and pathology reports to confirm diagnoses before you travel.
Bookimed Expert Insight: Anadolu Medical Center stands out for bone cancer cases because it holds European Society for Medical Oncology accreditation and ESMO-certified specialists. Their multidisciplinary boards allow a medical oncologist and orthopedist to review your files simultaneously. This dual-review is critical for determining if a limb-sparing surgery is viable before you book a flight.
Patient Consensus: Patients note that sending imaging and pathology slides first is essential for confirming if travel is necessary. Many emphasize having recent blood work ready, as specialists often request LDH and CBC levels to evaluate surgical fitness.
Choose JCI-accredited facilities in Istanbul specializing in orthopedic oncology and multidisciplinary limb-salvage surgery. Look for centers like Anadolu Medical Center or Memorial Hospitals. These clinics feature expert teams using PET-CT and MRI to plan complex bone reconstructions. Turkey ranks as the top destination for international patients.
Bookimed Expert Insight: Data shows a clear quality gap between general hospitals and high-volume oncology clusters like Memorial and Anadolu. While most Turkish clinics hold JCI labels, only a few like Anadolu Medical Center maintain Johns Hopkins Medicine affiliations. This link provides patients access to Western-standard protocols for rare sarcomas at approximately $17,000 to $25,000. These specific centers report managing 65,000 to 1,000,000 patients every year.
Patient Consensus: Patients note it is vital to confirm the hospital handles pathology, surgery, and physical therapy in one pathway. They emphasize choosing surgeons who focus specifically on bone tumors rather than general orthopedics.